KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) EBIT Margin: 2010-2015

Historic EBIT Margin for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to -119.80%.

  • Biocryst Pharmaceuticals' EBIT Margin rose 23876.00% to -119.80% in Q3 2015 from the same period last year, while for Sep 2015 it was -83.06%, marking a year-over-year increase of 11422.00%. This contributed to the annual value of -336.35% for FY2014, which is 15912.00% down from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported EBIT Margin of -119.80% as of Q3 2015, which was down 588.36% from 24.53% recorded in Q2 2015.
  • Biocryst Pharmaceuticals' EBIT Margin's 5-year high stood at 877.24% during Q2 2012, with a 5-year trough of -1,478.93% in Q2 2013.
  • Its 3-year average for EBIT Margin is -357.09%, with a median of -213.59% in 2014.
  • Per our database at Business Quant, Biocryst Pharmaceuticals' EBIT Margin soared by 108,881bps in 2012 and then tumbled by 235,617bps in 2013.
  • Quarterly analysis of 5 years shows Biocryst Pharmaceuticals' EBIT Margin stood at -211.37% in 2011, then surged by 108,881bps to 877.24% in 2012, then crashed by 235,617bps to -59.94% in 2013, then tumbled by 21,835bps to -278.30% in 2014, then spiked by 23,876bps to -119.80% in 2015.
  • Its last three reported values are -119.80% in Q3 2015, 24.53% for Q2 2015, and -211.40% during Q1 2015.